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Intestinal microbiota has critical importance in pathogenesis of intestinal infection; 
however, the role of intestinal microbiota in intestinal immunity during enterotoxigenic 
Escherichia coli (ETEC) infection is poorly understood. The present study tested the 
hypothesis that the intestinal microbiota is associated with intestinal interleukin-17 
(IL-17) expression in response to ETEC infection. Here, we found ETEC infection 
induced expression of intestinal IL-17 and dysbiosis of intestinal microbiota, increasing 
abundance of γ-aminobutyric acid (GABA)-producing Lactococcus lactis subsp. lactis. 
Antibiotics treatment in mice lowered the expression of intestinal IL-17 during ETEC 
infection, while GABA or L. lactis subsp. lactis administration restored the expression 
of intestinal IL-17. L. lactis subsp. lactis administration also promoted expression of 
intestinal IL-17 in germ-free mice during ETEC infection. GABA enhanced intestinal 
IL-17 expression in the context of ETEC infection through activating mechanistic target 
of rapamycin complex 1 (mTORC1)-ribosomal protein S6 kinase 1 (S6K1) signaling. 
GABA–mTORC1 signaling also affected intestinal IL-17 expression in response to 
Citrobacter rodentium infection and in drug-induced model of intestinal inflammation. 
These findings highlight the importance of intestinal GABA signaling in intestinal IL-17 
expression during intestinal infection and indicate the potential of intestinal microbiota-
GABA signaling in IL-17-associated intestinal diseases.
Keywords: intestinal microbiota, gaBa, il-17, mTOrc1, eTec, Lactococcus lactis
Abbreviations: EGR-2, early growth response protein 2; ETEC, enterotoxigenic Escherichia coli; Foxp3, forkhead box P3; 
GABA, γ-aminobutyric acid; GFI-1, growth factor independent 1; HIF-1α, hypoxia-inducible factor 1 α; IL-17, interleukin-17; 
mTORC1, mechanistic target of rapamycin complex 1; PCNA, proliferating cell nuclear antigen; RORγt, RAR-related orphan 
receptor gamma t; S6K, ribosomal protein S6 kinase.
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inTrODUcTiOn
The intestinal microbiota has critical importance in intestinal 
infections by increasing colonization resistance and promoting 
pathogen clearance after infection (1, 2). For example, Clostridium 
difficile infection, which is the leading health care-associated 
illness, usually follows the disruption of the indigenous gut 
microbiota after antibiotic treatment, leading to the loss of colo-
nization resistance against C. difficile (2–4). The gut microbiota 
also affects intestinal infections by mediating the host innate and 
adaptive immune responses (5, 6). For example, germ-free mice 
are highly susceptible to Listeria monocytogenes infection because 
of impaired activation and accumulation of phagocytes to the site 
of infection (6).
Interleukin (IL)-17 promotes local chemokine production to 
recruit monocytes and neutrophils to sites of inflammation and 
is thus important in mediating protection against pathogens, 
especially against extracellular pathogens (7). IL-17 combats the 
microbes attacking epithelial layers and has critical functions in 
protecting against bacterial infection at mucosal sites (8). IL-17 
is also thought to play major roles in the development and patho-
genesis of various autoimmune diseases, including rheumatoid 
arthritis, psoriasis vulgaris, multiple sclerosis, and inflammatory 
bowel disease (9, 10).
Intestinal expression of IL-17 is induced after intestinal 
infection by most pathogens (11–13). For example, Citrobacter 
rodentium or Salmonella infection promotes intestinal IL-17 
expression by enteric innate T helper type 17 (iTh17) cells (12). 
Enterotoxigenic Escherichia coli (ETEC) is a common cause of 
diarrhea in humans and livestock (14). Previous investigations 
have found that ETEC infection triggers intestinal IL-17 expres-
sion (15, 16). However, the underlying mechanisms are largely 
unknown. The present study tested the hypothesis that the intes-
tinal microbiota is associated with intestinal IL-17 expression in 
response to ETEC infection.
We confirmed that ETEC promotes intestinal IL-17 expres-
sion in piglets and mice and showed that the activation of the 
mechanistic target of rapamycin complex 1 (mTORC1)-growth 
factor independence 1 (GFI-1) signaling mediates intestinal 
IL-17 expression in the context of ETEC infection. We clarified 
that γ-aminobutyric acid (GABA) signaling is critical to activat-
ing the mTORC1–GFI-1–IL-17 pathway during ETEC infection, 
and this signaling is largely dependent on the intestinal GABA-
producing strain Lactococcus lactis subsp. lactis.
MaTerials anD MeThODs
Bacterial strains and antibodies
This study involved the use of an E. coli F4-producing strain 
W25K (hereafter referred as ETEC; O149:K91, K88ac; LT, STb, 
EAST), which was isolated from a piglet with diarrhea (17). ETEC 
W470 (O4:F18; STa, STb, LT), W817 (O107:F18; STb), and W616 
(F18; STa) were also isolated from piglets with diarrhea, while the 
Shiga-like toxin producing E. coli (W197, SLT-IIe) was isolated 
from a piglet with edema disease (18). These strains of bacteria 
were cultured in LB medium. L. lactis subsp. lactis (ATCC19435) 
was cultured in M17 medium. C. rodentium (DBS100) was 
cultured in LB medium. Antibodies against RAR-related orphan 
receptor gamma t (RORγt) (Sc-14196), forkhead box P3 (Foxp3) 
(Sc-28705), growth factor independent 1 (GFI-1) (Sc-8558), early 
growth response protein 2 (EGR-2) (Sc-20690), p85 (Sc-1637), 
phosphorylated protein kinase B (Akt) (Sc7985-R), GAT-2 (Sc-
7668), actin (Sc-47778), and proliferating cell nuclear antigen 
(PCNA) (Sc-56) were purchased from Santa Cruz Biotechnology, 
Inc. (Dallas, TX, USA). Antibodies against mTOR (CST 2972), 
p-mTOR (CST 5536), p-p70 S6 Kinase (CST 9205), p-4E-BP1 
(CST 9451), p-AMP-activated protein kinase (AMPK) (CST 
2535), hypoxia-inducible factor 1 α (HIF-1α) (CST 14179), and 
p70 S6 Kinase 2 (CST 14130) were purchased from Cell Signaling 
Technology (Danvers, MA, USA).
eTec infection in Piglets
This study was approved and conducted according to the 
guidelines of the Institute of Subtropical Agriculture, Chinese 
Academy of Sciences and Southwest University. Piglets (Landrace 
Yorkshire; 18  days old) were purchased from ZhengDa Co., 
Chongqing, China. ETEC infection in piglets was established 
according to previous reports (19, 20). The jejunum samples were 
collected. Samples were stored at −80°C until processing.
Mice
TCR delta knockout mice were provided by Prof. Zhinan Yin, 
from Jinan University (Guangzhou, China). Rag 1 knockout mice 
were bought from Nanjing University (Nanjing, China). Germ-
free mice were generated and provided by Prof. Hong Wei, from 
Third Military Medical University (Chongqing, China), and these 
mice were maintained in sterile Trexler-type isolators. ICR mice 
(6 weeks of age) were purchased from SLAC Laboratory Animal 
Central (Changsha, China). Experiments in mice were conducted 
according to the guidelines of the Laboratory Animal Ethical 
Commission of the Chinese Academy of Sciences.
eTec infection in Mice
Mice were orally gavaged with 108 CFUs of ETEC or other strains 
of E. coli. At 6-h postinfection, mice were sacrificed to collect 
the jejunum, ileum, and mesenteric lymph node. In some experi-
ments, mice were treated with rapamycin (Fisher Scientific) at 
2.5  mg/kg/d (i.p. injection) for six consecutive days prior to 
other manipulations. In experiments involving the inhibition 
of GABA signaling, mice were intraperitoneally injected with 
20 mg/kg bicuculline (Dalian Meilun Bio. Tech. Co., Ltd., Dalian, 
China), 120  mg/kg CGP-35348 (Tocris Bioscience), 80  mg/
kg l-allylglycine (Aladdin Industrial Corporation, China), or 
100 mg/kg semicarbazide (Sangon Biotech Co., Ltd., Shanghai, 
China) at 30 min prior to other manipulations. For the inhibi-
tion of S6K1, mice were intraperitoneally injected with 75 mg/
kg/d PF-4708671 (S2163, Selleck) for six consecutive days. In 
some experiments, mice were intraperitoneally injected with 
GABA (Aladdin Industrial Corporation, China) at dosages of 
40 μg//kg to 40 mg/kg at 30 min prior to other manipulations 
[the physiologic level of GABA in mouse serum is about 2 mg/
kg (21), while in human (adults), it is about 100–400  µg/kg]. 
For antibiotics treatment, mice received drinking water contain-
ing streptomycin (1.0  g/L, Sigma), ampicillin (1.0  g/L, Sigma), 
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gentamicin (1.0  g/L, Sigma), and vancomycin (0.5  g/L, Sigma) 
for 1  week before ETEC infection. For the supplementation of 
GABA to antibiotics-treated mice, mice received drinking water 
containing antibiotics (1.0 g/L streptomycin, 1.0 g/L ampicillin, 
1.0 g/L gentamicin, and 0.5 g/L vancomycin) and GABA (1.0 g/L 
or 5.0 g/L) for 1 week before ETEC infection. For L. lactis subsp. 
lactis inoculation into antibiotics-treated mice, mice received 
drinking water containing antibiotics (1.0  g/L streptomycin, 
1.0 g/L ampicillin, 1.0 g/L gentamicin, and 0.5 g/L vancomycin) 
for 6 days, and then orally inoculated with L. lactis subsp. lactis at 
a dosage of 108 CFUs at 24 h before ETEC infection. For L. lactis 
subsp. lactis inoculation into germ-free mice, mice were orally 
inoculated with L. lactis subsp. lactis at a dosage of 108 CFUs at 
7 days before ETEC infection.
L. lactis subsp. lactis inoculation in Mice
For L. lactis subsp. lactis inoculation into normal mice, mice were 
orally inoculated with L. lactis subsp. lactis at a dosage of 108 CFUs 
for five consecutive days. For GABA signaling inhibition, mice 
were intraperitoneally injected with 120  mg/kg CGP-35348 at 
5 days postinoculation. The jejunum samples were collected for 
further analysis at 5 days postinoculation (6-h post-CGP-35348 
treatment).
L. lactis subsp. lactis inoculation in Piglets
For L. lactis subsp. lactis inoculation in piglets, piglets were orally 
inoculated with L. lactis subsp. lactis at dose of 1010, while the con-
trol piglets received some volume of M17 medium. The jejunum 
samples were collected for analysis at 7 days postinoculation.
C. rodentium infection in Mice
Mice (6  weeks of age) were orally gavaged with 108  CFUs of 
C. rodentium (DBS100). For rapamycin treatment, mice were 
treated with rapamycin at 2.5 mg/kg/d (i.p. injection) at 1–7 days 
postinfection. For semicarbazide treatment, mice were treated 
with semicarbazide at 100 mg/kg/d (i.p. injection) at 1, 3, 5, and 
7 days postinfection. In some experiments, mice were intraperi-
toneally injected with 20 mg/kg bicuculline or 120 mg/kg CGP-
35348 at 7 days postinfection. The colon samples from all groups 
were collected for further analysis at 7  days postinfection (6-h 
post-bicuculline or CGP-35348 treatment).
5-Fluorouracil Treatment in Mice
ICR mice (6 weeks of age) were intraperitoneally injected with 
300 mg/kg 5-fluorouracil (Sigma-Aldrich). For the inhibition of 
GABA signaling, mice received intraperitoneal administration 
of 20 mg/kg bicuculline or 100 mg/kg semicarbazide at 30 min 
prior to 5-fluorouracil treatment. The jejunum was collected at 
6-h posttreatment for further analysis.
lymphocyte isolation from Jejunum
Lamina propria lymphocytes from jejunum were obtained accord-
ing to previous procedures (12, 22, 23). Briefly, jejunum tissue 
was extracted, opened longitudinally to wash luminal contents. 
Jejunum (cleared the visible PP) was cut into 0.5- to 1-cm seg-
ments that were incubated three times (37°C, 20 min, 250 rpm) 
in HBSS/HEPES medium (Life Technologies) containing 5 mM 
EDTA to remove the epithelial cells. Thereafter, the tissue seg-
ments were minced and digested in digestion buffer [HBSS + 5% 
FBS containing type VIII collagenase at 1.5  mg/mL (Sigma)] 
for 30-min incubations at 37°C. Digested material was passed 
through a 100-µm cell strainer, and the cells were collected by 
centrifugation, washed twice in DMEM, and then passed through 
a 40-µm cell strainer to obtain lamina propria lymphocytes from 
the jejunum.
Flow cytometry analysis
Lymphocytes isolated from mouse jejunal lamina propria were 
stained with cell surface markers of CD3 (FITC-CD3, 100203, 
Biolegend), CD4 (PE-CD4, 100407, Biolegend), or TCR γδ 
(PE-TCR γδ, 118107, Biolegend). For the analysis of intracellular 
cytokine, lymphocytes or CD4+ T cells were stimulated with PMA 
(50 ng/mL), ionomycin (1 µg/mL), and monensin (3 µg/mL) for 
5 h. After staining with cell surface markers, intracellular cytokine 
staining was performed with a fixation and permeabilization kit 
(eBioscience) and IL-17A Ab (APC-IL-17A, 506195, Biolegend) 
in accordance with the manufacturer’s instructions. Flow cytom-
etry was performed on a FACSCalibur (BD Biosciences) and data 
were analyzed using the FlowJo Software (Tree Star).
Metabolite Profiling analysis
Metabolite concentrations in piglet jejunal samples were quanti-
fied using gas chromatography/mass spectrometry (GC–MS) 
according to the previous work (19).
rT-Pcr
Real-time PCR was performed according to our previous study 
(20, 24). Primers (Table S1 in Supplementary Material) were 
selected according to previous references. β-Actin was used as an 
internal control to normalize target gene transcript levels.
immunoblotting
Immunoblotting was performed according to our previous study 
(20, 24). Signal intensity was digitally quantified and normalized 
to actin or PCNA protein abundance.
Th17 cell Differentiation
Naive CD4+ T cells were isolated from mouse splenocytes 
using a CD4+CD62L+ T cell isolation kit II (Miltenyi Biotec, 
purity > 95%). For Th17 differentiation, cells were stimulated with 
anti-CD3 (2 µg/mL, 100313, Biolegend) and anti-CD28 (2.0 µg/
mL, 102111, Biolegend) supplemented with 5  ng/ml TGF-β1 
(7666-MB-005, RD), 20 ng/mL IL-6 (575702, Biolegend), 10 µg/
mL anti-IFN-γ (505812, Biolegend), and 10  µg/mL anti-IL-4 
(504107, Biolegend) for 1–3 days. l-Allylglycine, semicarbazide, 
and rapamycin were used at 5 mM, 4 mM, and 3 µM, respectively.
statistical analyses
Data shown are the means ±  SEM. Data between two groups 
were analyzed by unpaired t test (Prism 6.0) if the data were in 
Gaussian distribution and had equal variance, or by unpaired t test 
with Welch’s correction (Prism 6.0) if the data were in Gaussian 
distribution but with unequal variance, or by non-parametric test 
(Mann–Whitney U test, Prism 6.0) if the data were not normally 
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distributed. Data among more than two groups were analyzed by 
the one-way ANOVA followed by Dunnett multiple comparisons 
(Prism 6.0) if the data were in Gaussian distribution and had 
equal variance, or analyzed by Kruskal–Wallis followed by Dunn’s 
multiple comparisons (Prism 6.0) if the data were not normally 
distributed. The Gaussian distribution of data was analyzed by 
D’Agostino–Pearson omnibus normality test (Prism 6.0) and 
Kolmogorov–Smirnov test (Prism 6.0). The variance of data was 
analyzed by homogeneity of variance test (SPSS 22.0) or Brown–
Forsythe test (Prism 6.0). The Bonferroni correction was applied 
for multiple pairwise comparisons. Differences with p <  0.05 
were considered significant.
resUlTs
eTec increases il-17 expression in 
Piglets and Mice
Enterotoxigenic Escherichia coli infection is known to promote 
IL-17 expression in piglets (15, 16), a finding we also validated. 
We infected Landrace × Yorkshire piglets with ETEC W25K, a 
strain originally isolated from a piglet with diarrhea (17). IL-17 
mRNA expression in the porcine jejunum was higher (about 
17-fold) in piglets infected with ETEC, as compared with unin-
fected controls (Figure 1A). Increased mRNA expression of other 
proinflammatory cytokines, including IL-6, IL-8, and TNF-α, was 
also detected in the jejunum after ETEC infection (Figure 1A).
In mice, at 6-h postinfection, ETEC colonized in the jejunum 
with load of about 5.9 log10 CFU/g and promoted the expression 
of Il-17 in the jejunum (Figure  1B). ETEC also promoted the 
expression of Il-17 in the ileum (Figure  1C). ETEC infection 
enhanced the abundance of RORγt (a key transcriptional regula-
tor of Th17 cells) in the cytoplasm and nuclei of mouse jejunum 
(Figure 1D) and ileum (Figure 1E).
Although the best-characterized cellular source of IL-17 is 
Th17 cells, a number of adaptive and innate immune cells, such 
as γδ T cells, natural killer T (NKT) cells, and even Paneth cells, 
are also the sources of IL-17 (11, 13). Similar to previous conclu-
sion that the increased IL-17+ cells at 5-h post-E. coli infection 
are CD3+ cells (25), we found that most of IL-17+ cells from 
ETEC-infected mouse jejunum were CD3+ cells. Thus, the ETEC-
infected mice had a higher percentage of CD3+IL-17+ cells in the 
jejunum compared with the controls (Figure 1F), suggesting that 
the increased expression of IL-17 at 6-h post-ETEC infection 
comes from T cells. Indeed, ETEC infection had little effect on 
the expression of Il-17 in the jejunum in Rag 1 knockout mice 
(mature T cell-depleted mice), while wild-type mice had higher 
expression of Il-17 in the jejunum compared to Rag 1 knockout 
mice during ETEC infection (Figure  1G). Unlike the previous 
study, which shows that the increased IL-17 is mainly produced 
by γδ T cells during early E. coli infection (25), we observed a 
higher percentage of CD3+CD4+IL-17+ cells in the jejunum from 
ETEC-infected mice as compared with uninfected mice, while 
the percentage of CD3+TCR γδ+IL-17+ cells in the jejunum 
did not differ between ETEC-infected mice and control mice 
(Figures 1H,I). Notably, Il-17 expression in the jejunum after 6 h 
of ETEC infection was similar between TCR delta−/− mice (γδ T 
cell-depleted mice) and wild-type mice (Figure 1J). In conclu-
sion, ETEC infection promotes the intestinal mRNA expression 
of IL-17 in piglets and mice.
eTec Promotes il-17 expression through 
mTOrc1 activation
A previous study has shown that ETEC infection inhibits the acti-
vation of NF-κB and mitogen-activated protein kinases pathways 
in the jejunum (20), indicating that new pathways are associ-
ated with expression of IL-17 during ETEC infection. Previous 
proteomic analysis indicated that ETEC infection upregulates 
ribosomal protein S6 kinase in the piglet jejunum (20), which 
suggests that ETEC infection may activate mTORC1 signaling. 
The mTORC1 has a critical role in Th17 responses and in IL-17 
expression (26). Indeed, the mTORC1 pathway was activated 
in piglets infected with ETEC, based on the higher abundance 
of phosphorylated mTORC1 and its downstream target S6K 
(Figure  2A). Phosphorylated mTORC1 abundance was also 
higher in ETEC-infected mice than that in uninfected controls 
(Figure 2B). To validate the possible roles of mTORC1 signal-
ing in the expression of IL-17 during ETEC infection, this study 
used rapamycin to inhibit the activation of mTORC1. Rapamycin 
treatment prior to ETEC infection prevented the increase in 
mTORC1 phosphorylation in the jejunum and ileum (Figure 2C) 
and reversed the increased Il-17 expression in mice infected with 
ETEC (Figure 2D). Similar to a previous report (27), rapamycin 
also inhibited Th17 cell differentiation from naïve T cells under 
Th17 polarization conditions in vitro (Figures 2E). In conclusion, 
ETEC infection promotes IL-17 expression through the activa-
tion of mTORC1 pathway.
eTec Promotes il-17 expression through 
the mTOrc1–egr-2 Pathway
Among the downstream targets of mTORC1 signaling, HIF-1α 
and S6K (S6K1 and S6K2) can regulate IL-17 expression (26). 
mTORC1 signaling activates HIF-1α, which promotes IL-17 
expression by activating RORγt and mediating Foxp3 degradation 
(26). ETEC infection decreased HIF-1α abundance and increased 
Foxp3 abundance in the cytoplasm of mouse jejunum compared 
to the controls (Figure 3A). Rapamycin treatment before ETEC 
infection increased HIF-1α abundance and lowered Foxp3 abun-
dance (Figure  3A). S6K2 (the nuclear-localized counterpart of 
S6K1) binds to RORγt to promote the nuclear translocation of 
RORγt, which can complex with HIF-1α and p300 in the nucleus 
to promote IL-17 expression (26). Although ETEC infection 
increased RORγt abundance, rapamycin had no effect on RORγt 
abundance (Figure 3B, top). Similarly, rapamycin did not affect 
on the abundance of HIF-1α and S6K2 in the nucleus of the 
mouse jejunum (Figure 3B, bottom), although ETEC infection 
reduced the nuclear abundance of HIF-1α and S6K2 in mouse 
jejunum (Figure 3B, bottom).
S6K1 promotes the expression of EGR-2, resulting in the 
inhibition of the GFI-1, which negatively regulates IL-17 expres-
sion without affecting Rorc expression (26). Although ETEC 
infection had little affect on Egr-2 expression in the mouse 
jejunum, rapamycin reduced Egr-2 expression in the mouse 
FigUre 1 | enterotoxigenic Escherichia coli (eTec) induces intestinal interleukin-17 (il-17) expression. (a) Relative mRNA expression of indicated 
cytokines in piglet jejunum samples (n = 6). (B) Relative mRNA expression of IL-17 in mouse jejunum. (c) Relative mRNA expression of IL-17 in mouse ileum. 
(D) Nuclear and cytoplasmic abundance of RAR-related orphan receptor gamma t (RORγt) in mouse jejunum samples. In this, and in all subsequent figures, the 
statistical data (mean ± SEM; n = 5) below the image indicate the relative band amount of indicated protein obtained by dividing the actin or proliferating cell nuclear 
antigen (PCNA) band intensity by the indicated band intensity in each lane. (e) Nuclear and cytoplasmic abundance of RORγt in mouse ileum samples. (F,h,i) ICR 
mice were infected with ETEC for 6 h, and lymphocytes from the jejunal lamina propria were isolated and stimulated for 5 h with PMA, ionomycin, and monensin, 
followed by flow cytometry analysis of the frequency of CD3+IL-17+ cells (F), CD3+CD4+IL-17+ cells (h), and CD3+TCR γδ+IL-17+ cells (i). (g) Relative mRNA 
expression of IL-17 in Rag1−/− mouse jejunum at 6-h post-ETEC infection. (J) Relative mRNA expression of IL-17 in TCR delta−/− mouse jejunum at 6-h post-ETEC 
infection. *indicates a statistically significant difference between two groups (p < 0.05), while **indicates p < 0.01, and ***indicates p < 0.001 [unpaired t test (a,J); 
Mann–Whitney test (F,h,i); Kruskal–Wallis test (g); Bonferroni correction was also used for (a)]. Data shown are representative of three independent experiments 
with n = 10 (B,c) or 5 (D,e) in each experiment, or representatives of two independent experiments with n = 4–7 (F–J) in each experiment.
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FigUre 2 | enterotoxigenic Escherichia coli (eTec) promotes intestinal interleukin-17 (il-17) mrna expression through mechanistic target of 
rapamycin complex 1 (mTOrc1) activation. (a) The activation of mTOR pathway in piglet jejunum (n = 5). (B) The activation of mTOR pathways in mouse 
jejunum or ileum. (c) Rapamycin pretreatment inhibits mTOR activation in mouse jejunum and ileum. (D) mRNA expression of IL-17 in mouse jejunum and ileum 
after rapamycin treatment. (e) Intracellular staining of the expression of IL-17 by CD4+ T cells cultured under the Th17-inducing conditions with or without rapamycin 
for 24 h. *indicates a statistically significant difference between two groups (p < 0.05) [unpaired t test (a,B); one-way ANOVA (c,D); Mann–Whitney test (e)]. Data 
shown are representative of four independent experiments with n = 5 (B,c) or 10 (D) in each experiment, or representatives of three independent experiments with 
n = 3 (e) in each experiment.
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jejunum (Figure 3C). ETEC infection reduced Gfi-1 expression 
in the mouse jejunum, while rapamycin prevented this reduction 
(Figure 3C). At the protein level, ETEC infection increased the 
abundance of EGR-2 and lowered the abundance of GFI-1 in the 
mouse jejunum, while rapamycin abolished the effects of ETEC 
infection (Figure 3D). These results indicate that ETEC induces 
intestinal IL-17 expression may through the S6K1–EGR-2–GFI-1 
axis. Intriguingly, ETEC infection increased Il-17 expression 
FigUre 3 | enterotoxigenic Escherichia coli (eTec) promotes interleukin-17 (il-17) expression through the mechanistic target of rapamycin complex 
1 (mTOrc1)–early growth response protein 2 (egr-2) pathway. (a) Hypoxia-inducible factor 1 α (HIF-1α) and Foxp3 protein abundance (n = 5). (B) RORγt, 
HIF-1α, and S6K2 abundance (n = 5). (c) EGR-2 and GFI-1 mRNA expression (n = 10). (D) EGR-2 and GFI-1 protein abundance (n = 5). (e) IL-17 mRNA expression 
in mouse jejunum (n = 10). (F) EGR-2 and GFI-1 abundance (n = 5). All these indicators were analyzed by RT-PCR (mRNA level) and immunblotting (protein level) in 
mouse jejunum at 6 h of post-ETEC infection. *indicates a statistically significant difference between two groups (p < 0.05), while **indicates p < 0.01 [one-way 
ANOVA (a–F)].
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in the jejunum, while PF-4708671 (S6K1 specific inhibitor) 
reduced Il-17 expression in the jejunum in ETEC-infected mice 
(Figure 3E). ETEC infection increased the abundance of EGR-2 
and decreased the abundance of GFI-1 in the mouse jejunum, 
while PF-4708671 treatment reversed this change during ETEC 
infection in mouse jejunum (Figure  3F). These data indicate 
ETEC promotes the IL-17 expression in the jejunum through 
the mTOR–S6K1–GFI-1 axis.
eTec Promotes il-17 expression through 
gaBa–mTOrc1–egr-2 signaling
Mechanistic target of rapamycin complex 1 is activated by amino 
acids and by the phosphatidylinositol 3-kinase (PI3K)/Akt path-
way, while it is inactivated by the AMPK (28, 29). ETEC infection 
inhibited the PI3K/Akt pathway and activated AMPK in piglet 
jejunum (Figures  4A,B). Thus, the activation of mTORC1 in 
response to ETEC infection may result from changes in amino 
acid concentration in the jejunum. Using GC–MS analysis, we 
found that eight amino acids significantly changed in abundance 
after ETEC infection (Figure  4C). The relative abundance of 
spermidine, glutamine, asparagine, citrulline, and ornithine 
decreased, while the relative abundance of glycine, taurine, and 
GABA increased after ETEC infection (Figure  4C). However, 
there was little change in mRNA expression of the activating 
transcription factor 4 (Figure  4D), an indicator of amino acid 
starvation (30), suggesting there was no overall amino acid star-
vation after ETEC infection.
As GABA was the most significantly increased amino acid 
(about fourfold), we hypothesized that GABA is responsible 
for increased IL-17 expression and mTORC1 activation during 
ETEC infection. Indeed, numerous investigations have shown 
that GABA signaling promotes mTORC1 activation (31–33). 
Treating mice with bicuculline (an antagonist of GABAA 
receptors) or with CGP-35348 (an antagonist of GABAB recep-
tors) lowered Il-17 expression in the jejunum during ETEC 
infection (Figure  4E). Bicuculline and CGP-35348 treatment 
also reversed the activation of mTORC1–EGR-2 signaling 
in mouse jejunum induced by ETEC infection (Figure  4F). 
GABA injection promoted Il-17 expression in mouse jejunum 
during ETEC infection, while rapamycin prevented expression 
of Il-17 caused by GABA injection (Figure 4G). Furthermore, 
treatment with l-allylglycine or semicarbazide (blockers of 
synthetic enzyme for GABA) reduced Il-17 expression in mouse 
jejunum during ETEC infection (Figure  4H). l-Allylglycine 
or semicarbazide treatment also prevented the activation of 
mTORC1–EGR-2 signaling in mouse jejunum caused by ETEC 
infection (Figure 4I).
To investigate whether GABA signaling regulates Th17 cell 
differentiation, naïve CD4+ T cells were isolated and differenti-
ated into Th17 cells under Th17 polarization conditions. In 
normal Th17 differentiation condition, about 3.0% of CD4+ T 
cells were differentiated into CD4+IL-17+ T cells after 3 days of 
differentiation; while l-allylglycine or semicarbazide decreased 
the percentage of CD4+IL-17+ T cells (Figure 4J). After 3 days 
of differentiation under normal Th17 polarization condi-
tions, CD4+ T cells had higher abundance of phosphorylated 
mTORC1, compared to the naïve CD4+ T cells (Figure  4K). 
Also, l-allylglycine decreased the abundance of phosphorylated 
mTORC1 (Figure 4K). Collectively, GABA signaling promotes 
IL-17 expression during infection though mTORC1–EGR-2 
signaling.
Microbiota-Derived gaBa Mediates il-17 
expression during eTec infection
Intestinal microbiota has critical roles in GABA production from 
glutamate (34, 35) and in regulation of intestinal IL-17 expres-
sion (36, 37). Our previous study has found that ETEC-infected 
piglets had a higher percentage of Lactococcus, compared to 
the controls (manuscript submitted). This result was supported 
by our current finding that ETEC-infected mice had higher 
numbers of L. lactis subsp. lactis, as compared with uninfected 
controls (Figure 5A). Within the intestinal microbiota, L. lactis 
subsp. lactis is one of the main GABA-producing strains (38, 39). 
Thus we hypothesized that the increased abundance of intestinal 
L. lactis subsp. lactis during ETEC infection is responsible for 
activated GABA–IL-17 signaling in the context of ETEC infec-
tion. Indeed, we found that piglets orally inoculated with L. 
lactis subsp. lactis (ATCC19435) has higher mRNA expression 
of IL-17 in the jejunum compared to the piglets without L. lactis 
subsp. lactis inoculation (Figure  5B). The GABA production 
activity of L. lactis subsp. lactis (ATCC19435) is about 210.4 µM 
(38, 39). Similar to the observation from piglets, L. lactis subsp. 
lactis inoculation in mice significantly promoted the expres-
sion of Il-17 in the jejunum compared to the mice without L. 
lactis subsp. lactis inoculation (Figure 5C). More importantly, 
inhibition of GABA signaling by CGP-35348 decreased the 
expression of Il-17 in the jejunum of mice with L. lactis subsp. 
lactis inoculation (Figure 5C). To further test this hypothesis, 
we treated mice with a mixture of antibiotics for 1  week to 
decrease the load of L. lactis subsp. lactis before ETEC infection. 
To increase the abundance of L. lactis subsp. lactis in antibiotics-
treated mice, we orally inoculated the L. lactis subsp. lactis to 
antibiotics-treated mice. The antibiotics-treated mice had a 
lower numbers of L. lactis subsp. lactis than the mice without 
antibiotics treatment (Figure  5D). After ETEC infection, we 
found that antibiotics-treated mice had lower expression of 
Il-17 in the jejunum compared to the mice without antibiotics 
treatment (Figure 5E). Oral inoculation of L. lactis subsp. lactis 
before ETEC infection increased the numbers of L. lactis subsp. 
lactis in the content of jejunum and rescued the expression of 
Il-17 during ETEC infection (Figures  5D,E). Interestingly, in 
antibiotics-treated mice, higher dosage of GABA supplementa-
tion also rescued the expression of Il-17 in the jejunum during 
ETEC infection (Figure 5F). In germ-free mice, L. lactis subsp. 
lactis administration before ETEC infection also promoted 
expression of Il-17 (Figure 5G). Collectively, intestinal GABA-
producing bacteria have vital importance in IL-17 expression 
during ETEC infection.
gaBa–mTOrc1 signaling Mediates il-17 
expression in Other Models
To validate the role of GABA–mTORC1 signaling in IL-17 
expression in other intestinal infectious models, we infected mice 
FigUre 4 | enterotoxigenic Escherichia coli (eTec) promotes interleukin-17 (il-17) expression through γ-aminobutyric acid (gaBa)-mechanistic target 
of rapamycin complex 1 (mTOrc1) signaling. (a) The activation of PI3K-p-Akt pathway in piglet jejunum (n = 5). (B) The abundance of phosphorylated AMP-
activated protein kinase (AMPK) in piglet jejunum (n = 5). (c) Relative amino acid concentrations in diarrheal piglets compared with uninfected piglets (n = 6). 
(D) Activating transcription factor 4 (ATF4) mRNA expression in piglet jejunum (n = 6). (e) mRNA expression of IL-17 after bicuculline or CGP-35348 treatment (n = 10). 
(F) mTORC1–GFI-1 activation after bicuculline or CGP-35348 treatment (n = 5). (g) mRNA expression of IL-17 after GABA injection (n = 10). (h) mRNA expression of 
IL-17 after l-allylglycine or semicarbazide treatment (n = 10). (i) mTORC1–early growth response protein 2 (EGR-2) activation after l-allylglycine or semicarbazide 
treatment (n = 5). (J) Intracellular staining of the expression of IL-17 by CD4+ T cells cultured under the Th17-inducing conditions with or without allyglycine or 
semicarbazide for 3 days. Results shown are representative of three independent experiments with n = 3 in each experiment. (K) The abundance of phosphorylated 
mTOR. Naïve CD4+ T cells were isolated (T0 cells) and cultured under the Th17-inducing conditions without (Th17 differ.) or with allyglycine (Th17 differ. + ALG) for 3 days. 
Results shown are representative of three independent experiments. The numbers indicate the relative band amount of p-mTOR protein in each sample obtained by 
dividing the actin band intensity by the p-mTOR band intensity in each lane. *indicates a statistically significant difference between two groups (p < 0.05), while **indicates 
p < 0.01, and ***indicates p < 0.001 [unpaired t test (a–D); one-way ANOVA (e–i); Kruskal–Wallis test (J); Bonferroni correction was also used for (c)].
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FigUre 5 | intestinal microbiota affects interleukin-17 (il-17) expression. (a) Bacterial counting of Lactococcus lactis subsp. lactis in enterotoxigenic 
Escherichia coli (ETEC)-infected mice and control mice. The jejunal contents were collect at 6-h post-ETEC infection for bacterial counting. (B) The mRNA 
expression of IL-17 in the jejunum was analyzed in piglets (n = 5). (c) The mRNA expression of IL-17 in the jejunum was analyzed in mice (n = 8). (D) Bacterial 
counting of L. lactis subsp. lactis in indicated models. (e) The mRNA expression of IL-17 in the jejunum was analyzed in indicated models. (F) The mRNA 
expression of IL-17 in the jejunum was analyzed in indicated models. (g) The mRNA expression of IL-17 in the mesenteric lymph node was analyzed in germ-free 
mice. Germ-free mice received L. lactis subsp. lactis or not at 1 week before ETEC infection. mRNA expression is relative to GF mice without L. lactis subsp. lactis 
administration (defined as 1; n = 5). Results shown are representative of two independent experiments with n = 5–8 (a,D,e) in each experiment, or of three 
independent experiments with n = 8 (F) in each experiment. *indicates a statistically significant difference between two groups (p < 0.05), while **indicates p < 0.01 
[Mann–Whitney test (a,g); unpaired t test with Welch’s correction (B); one-way ANOVA (c–F)].
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FigUre 6 | γ-aminobutyric acid (gaBa)-mechanistic target of rapamycin complex 1 (mTOrc1) signaling mediates mrna expression interleukin-17 
(il-17) in other models. (a) Rapamycin prevents mRNA expression of IL-17 induced by W470, W197, W817, or W616 (n = 10). (B) Bicuculline prevents mRNA 
expression of IL-17 induced by W470 (n = 10). (c) Inhibition of GABA–mTORC1 signaling inhibits mRNA expression of IL-17 in the colon during Citrobacter 
rodentium infection (n = 10). (D) Inhibition of GABA signaling inhibits the increase in mRNA expression of IL-17 induced by 5-fluorouracil (5-FU) (n = 10). *indicates a 
statistically significant difference between two groups (p < 0.05), while **indicates p < 0.01, and ***indicates p < 0.001 [one-way ANOVA (a–D)].
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with different ETEC strains and with Shiga-like toxin producing 
E. coli. In mouse model, E. coli W470, W197, W817, and W616 
increased Il-17 expression in the jejunum at 6-h postinfection 
(Figure 6A). Pretreatment with rapamycin prevented expression 
of Il-17 in the jejunum caused by W470, W197, W817, and W616 
at 6-h postinfection (Figure 6A). Similar to our previous W25K 
infection, bicuculline treatment reversed the increase in Il-17 
expression caused by W470 in mouse jejunum (Figure 6B). In C. 
rodentium infected mice, the expression of Il-17 in the colon was 
higher than in control mice (Figure  6C). Interestingly, higher 
abundance of L. lactis subsp. lactis was also observed in the 
colon during C. rodentium infection (7.7 ±  0.03  log10  CFU/g 
in infected mice vs. 6.9 ±  0.08  log10  CFU/g in control mice). 
Rapamycin treatment lowered the colonic expression of Il-17 
(Figure  6C), indicating that inhibition of mTORC1 pathway 
reduced the expression of Il-17 in the colon during C. rodentium 
infection. Furthermore, the inhibition of GABA signaling by 
semicarbazide, bicuculline, or CGP-35348 also lowered the 
expression of Il-17 in the colon in the context of C. rodentium 
infection (Figure 6C). 5-Fluorouracil (5-FU) is frequently used 
in cancer treatment and also induces intestinal inflammation 
(40, 41). 5-FU enhanced Il-17 expression in the jejunum at 
6-h postinjection (Figure  6D). Semicarbazide or bicuculline 
treatment prevented the increase in Il-17 expression caused by 
5-FU (Figure  6D). In summary, GABA–mTORC1 signaling 
also functions in intestinal IL-17 expression in other intestinal 
inflammatory models.
DiscUssiOn
Besides promoting local inflammation, emerging evidence shows 
that Th17 cells secrete IL-26, which kills extracellular bacteria 
through membrane-pore formation and triggers the production 
of interferon alpha through binding to bacterial DNA (42). Thus, 
Th17 response has a critical role in protection against extracel-
lular bacterial infection. Similar to previous studies (15, 16), we 
observed that ETEC infection promotes intestinal IL-17 expres-
sion in piglet and mouse models. The increased expression of IL-17 
during ETEC infection may come from adaptive cells (e.g., Th17 
cells), or innate immune cells, such as innate lymphoid cells-3, γδ 
T cells, and NKT cells (11, 13). Unlike previous conclusion that 
increased IL-17 is mainly produced by γδ T cells at 5-h post-E. 
coli infection (25), this study indicates that a significant portion 
of the IL-17 comes from Th17 cells at 6-h post-ETEC infection. 
However, intestinal Th17 cell responses after bacterial infection 
(e.g., C. rodentium and E. coli O157) needs the epithelial adhesion 
of pathogens and is observed at 5–14 days postinfection (43, 44). 
Thus, the exact cellular source for increase IL-17 expression at 
6-h post-ETEC infection needs further investigation. Indeed, 
enteric iTh17 has been observed at early time of Citrobacter and 
Salmonella infection (12).
Mechanistic target of rapamycin complex 1 is a conserved Ser/
Thr protein kinase that functions as a sensor of growth factors, 
nutrients, and energy to promote anabolic cellular metabolism 
and functions as a master controller of cell growth (45). Recent 
studies have shown that mTORC1 signaling is crucially involved 
in Th17 cells differentiation and IL-17 expression (26). Inhibition 
of mTORC1 signaling with rapamycin reduces IL-17 expression 
in various inflammatory models (46–48). Similarly, we showed 
that mTORC1 signaling mediates the expression of IL-17 after 
intestinal ETEC infection, and this result is similar to the previous 
reports that mTORC1 signaling has a critical role in IL-17 expres-
sion (26). Likewise, another study has shown that rapamycin 
treatment inhibits the expression of IL-17 during Campylobacter 
jejuni infection (49). mTORC1–S6K1–EGR-2–GFI-1 axis 
is involved in IL-17 expression in ETEC infection. GFI-1, a 
downstream target of mTORC1–S6K1 axis (26), is a negative 
regulator of IL-17 expression and Th17 differentiation, and the 
downregulation of GFI-1 is important for IL-17 expression (26). 
However, the expression of IL-17 in the context of ETEC infection 
is independent of the S6K2 mediating nuclear translocation of 
RORγt, and HIF-1α pathway, which promotes IL-17 expression 
through: (a) transcriptional activation of RORγt in the cytoplasm, 
(b) collaboration with RORγt to promote IL-17 expression in the 
nucleus, through mechanisms involving p300 recruitment and 
histone acetylation, and (c) inhibition of Treg differentiation by 
targeting Foxp3 for ubiquitination and proteasomal degradation 
(26). Interestingly, ETEC infection reduces the abundance of 
HIF-1α. Although the underlying mechanisms are unknown, our 
results may indicate a complex regulatory role for mTORC1 in 
HIF-1α production, Th17 differentiation, and IL-17 expression.
We found that GABA signaling mediates intestinal IL-17 
expression in ETEC infection through activation of mTORC1 
signaling. In starvation conditions that normally inhibit 
mTORC1 signaling, the addition of GABA also increases S6 
phosphorylation, suggesting that GABA signaling activates 
mTORC1 signaling even in starvation conditions (33). Recently, 
GABA has been suggested to exert a potential anti-inflammatory 
action by inhibiting major inflammatory events mediated by 
different immune cells. For example, increasing GABAergic 
activity ameliorates inflammation in experimental autoimmune 
encephalomyelitis (50). Oral GABA treatment ameliorates the 
inflammatory process both in non-obese diabetic mice (51) and 
in a mouse model of rheumatoid arthritis (52). Also, GABAA 
agonists are beneficial in experimental encephalomyelitis (50) 
and allergic asthma (53), and GABAB agonists exhibit a positive 
effect in dermatitis models (54). However, few investigations have 
addressed the possible action of GABA on intestinal inflam-
mation during infection. Different from these previous reports 
(50–54), here we found that GABA promotes intestinal IL-17 
expression. Similarly, dendritic cells increase GABA secretion 
in  vitro after Toxoplasma gondii infection and exhibit a hyper-
migratory phenotype because increased GABA activates GABAA 
receptor-mediated currents in T. gondii-infected dendritic cells 
(55). The inactivation of GABA signaling in T.  gondii-infected 
dendritic cells by inhibition of GABA synthesis or transportation, 
or by blockade of GABAA receptor, results in impaired function 
of dendritic cells in  vitro, including transmigration capacity, 
motility, and chemotactic response to CCL19 (55).
The gut microbiota affects numerous biological functions 
(56, 57) and is linked to the pathogenesis of various diseases, 
such as obesity (58), cancer (59), and liver cirrhosis (60). The 
influence of the gut microbiota on host physiological functions 
and the pathogenesis of disease may result from the activity of 
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the microbiome and its metabolic products (56). Gut microbes 
produce various biologically active molecules, such as GABA, 
short-chain fatty acids, and biogenic amines (such as histamine), 
to actively regulate host health and disease states (56). For 
example, Lactobacillus rhamnosus JB-1 converts glutamate into 
GABA and alters GABA signaling in the brain, resulting in a 
reduction in stress-induced corticosterone, and in anxiety- and 
depression-related behavior (61). We found that ETEC infec-
tion induces a dysbiosis of the intestinal microbiota, especially 
promoting a higher percentage of GABA-producing L. lactis in 
the jejunum. Intestinal GABA-producing L. lactis has critical role 
in IL-17 expression during infection. However, the L. lactis used 
for GABA production in this study is not an inhabitant of the 
GI tract of either mice or piglets, thus it is interesting to test 
the function of GABA-producing L. lactis isolated from pigs. 
Also, it is interesting to explore the mechanism responsible for 
increased abundance of L. lactis during ETEC infection. Besides 
GABA, whether other products from L. lactis, or other members 
of intestinal microbiota are also involved in the pathogenesis of 
ETEC infection remain to know.
In conclusion, we propose the following scenario for 
how intestinal pathogens (i.e., ETEC) mediates intestinal 
IL-17 expression. During ETEC infection, ETEC induces the 
dysbiosis of gut microbiota, increasing GABA-producing L. 
lactis subsp. lactis. The increased content of GABA promotes 
IL-17 expression during infection through mTORC1–S6K1–
EGR-2–GFI-1 pathway. This discovery has great potential to 
manipulate intestinal GABA–mTORC1 signaling and intestinal 
GABA-producing bacteria to treat intestinal chronic inflamma-
tory diseases involving IL-17 expression. Our findings further 
support the notion that functional amino acids (e.g., glutamate 
and glutamine) play an important role in the immunity and 
health of animals (62–64).
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